134886-06-9

Upstream product

• 134861-33-9 (R)-2-tert-Butoxycarbonylamino-propionic acid (6E,8E,10E,16Z)-(5R,13S,14R,15R)-22-(tert-butyl-dimethyl-silanyloxy)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-2-aza-bicyclo[18.3.1]tetracosa-1⁽²⁴⁾,6,8,10,16,20,22-heptaen-13-yl ester 
• 134861-32-8 (6E,8E,10E,16Z)-(5R,13S,14S,15R)-22-(tert-Butyl-dimethyl-silanyloxy)-13,15-dihydroxy-5-methoxy-14,16-dimethyl-2-aza-bicyclo[18.3.1]tetracosa-1⁽²⁴⁾,6,8,10,16,20,22-heptaen-3-one 
• 117543-72-3 (+)-trienomycinol 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 98-89-5 Cyclohexanecarboxylic acid 

Relevant academic research and scientific papers

ISOLATION AND STRUCTURE DETERMINATION OF (+)-TRIENOMYCIN F. AN ENDGAME SYNTHETIC STRATEGY FOR THE TRIENOMYCIN FAMILY OF ANTITUMOR ANTIBIOTICS

A new trienomycin antibiotic, (+)-trienomycin F (4), has been isolated and characterized.The structure was elucidated via spectroscopic comparison with semisynthetic 4 prepared from (+)-trienomycinol (5).The latter sequence implemented an endgame syntheti